Literature DB >> 12931049

Effect of Box-Cox transformation on power of Haseman-Elston and maximum-likelihood variance components tests to detect quantitative trait Loci.

C J Etzel1, S Shete, T M Beasley, J R Fernandez, D B Allison, C I Amos.   

Abstract

Non-normality of the phenotypic distribution can affect power to detect quantitative trait loci in sib pair studies. Previously, we observed that Winsorizing the sib pair phenotypes increased the power of quantitative trait locus (QTL) detection for both Haseman-Elston (HE) least-squares tests [Hum Hered 2002;53:59-67] and maximum likelihood-based variance components (MLVC) analysis [Behav Genet (in press)]. Winsorizing the phenotypes led to a slight increase in type 1 error in H-E tests and a slight decrease in type I error for MLVC analysis. Herein, we considered transforming the sib pair phenotypes using the Box-Cox family of transformations. Data were simulated for normal and non-normal (skewed and kurtic) distributions. Phenotypic values were replaced by Box-Cox transformed values. Twenty thousand replications were performed for three H-E tests of linkage and the likelihood ratio test (LRT), the Wald test and other robust versions based on the MLVC method. We calculated the relative nominal inflation rate as the ratio of observed empirical type 1 error divided by the set alpha level (5, 1 and 0.1% alpha levels). MLVC tests applied to non-normal data had inflated type I errors (rate ratio greater than 1.0), which were controlled best by Box-Cox transformation and to a lesser degree by Winsorizing. For example, for non-transformed, skewed phenotypes (derived from a chi2 distribution with 2 degrees of freedom), the rates of empirical type 1 error with respect to set alpha level=0.01 were 0.80, 4.35 and 7.33 for the original H-E test, LRT and Wald test, respectively. For the same alpha level=0.01, these rates were 1.12, 3.095 and 4.088 after Winsorizing and 0.723, 1.195 and 1.905 after Box-Cox transformation. Winsorizing reduced inflated error rates for the leptokurtic distribution (derived from a Laplace distribution with mean 0 and variance 8). Further, power (adjusted for empirical type 1 error) at the 0.01 alpha level ranged from 4.7 to 17.3% across all tests using the non-transformed, skewed phenotypes, from 7.5 to 20.1% after Winsorizing and from 12.6 to 33.2% after Box-Cox transformation. Likewise, power (adjusted for empirical type 1 error) using leptokurtic phenotypes at the 0.01 alpha level ranged from 4.4 to 12.5% across all tests with no transformation, from 7 to 19.2% after Winsorizing and from 4.5 to 13.8% after Box-Cox transformation. Thus the Box-Cox transformation apparently provided the best type 1 error control and maximal power among the procedures we considered for analyzing a non-normal, skewed distribution (chi2) while Winzorizing worked best for the non-normal, kurtic distribution (Laplace). We repeated the same simulations using a larger sample size (200 sib pairs) and found similar results. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12931049     DOI: 10.1159/000072315

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  11 in total

1.  Genomic imprinting and linkage test for quantitative-trait Loci in extended pedigrees.

Authors:  Sanjay Shete; Xiaojun Zhou; Christopher I Amos
Journal:  Am J Hum Genet       Date:  2003-09-16       Impact factor: 11.025

2.  Selection of eating-disorder phenotypes for linkage analysis.

Authors:  Cynthia M Bulik; Silviu-Alin Bacanu; Kelly L Klump; Manfred M Fichter; Katherine A Halmi; Pamela Keel; Allan S Kaplan; James E Mitchell; Alessandro Rotondo; Michael Strober; Janet Treasure; D Blake Woodside; Vibhor A Sonpar; Weiting Xie; Andrew W Bergen; Wade H Berrettini; Walter H Kaye; Bernie Devlin
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-11-05       Impact factor: 3.568

3.  Haseman-Elston regression in ascertained samples: importance of dependent variable and mean correction factor selection.

Authors:  Ritwik Sinha; Courtney Gray-McGuire
Journal:  Hum Hered       Date:  2007-09-26       Impact factor: 0.444

4.  An efficient method to handle the 'large p, small n' problem for genomewide association studies using Haseman-Elston regression.

Authors:  Bujun Mei; Zhihua Wang
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

5.  Identification of quantitative trait loci for fibrin clot phenotypes: the EuroCLOT study.

Authors:  Frances M K Williams; Angela M Carter; Bernet Kato; Mario Falchi; Lise Bathum; Gabriela Surdulescu; Kirsten Ohm Kyvik; Aarno Palotie; Tim D Spector; Peter J Grant
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-01-15       Impact factor: 8.311

6.  Rank-based inverse normal transformations are increasingly used, but are they merited?

Authors:  T Mark Beasley; Stephen Erickson; David B Allison
Journal:  Behav Genet       Date:  2009-06-14       Impact factor: 2.805

7.  Genome-wide association mapping for seedling and field resistance to Puccinia striiformis f. sp. tritici in elite durum wheat.

Authors:  Weizhen Liu; Marco Maccaferri; Peter Bulli; Sheri Rynearson; Roberto Tuberosa; Xianming Chen; Michael Pumphrey
Journal:  Theor Appl Genet       Date:  2016-12-30       Impact factor: 5.699

8.  The Box-Cox power transformation on nursing sensitive indicators: does it matter if structural effects are omitted during the estimation of the transformation parameter?

Authors:  Qingjiang Hou; Jonathan D Mahnken; Byron J Gajewski; Nancy Dunton
Journal:  BMC Med Res Methodol       Date:  2011-08-19       Impact factor: 4.615

9.  Genetic imprinting analysis for alcoholism genes using variance components approach.

Authors:  Sanjay Shete; Robert Yu
Journal:  BMC Genet       Date:  2005-12-30       Impact factor: 2.797

10.  Sex, age and generation effects on genome-wide linkage analysis of gene expression in transformed lymphoblasts.

Authors:  Jagadish Rangrej; Joseph Beyene; Pingzhao Hu; Andrew D Paterson
Journal:  BMC Proc       Date:  2007-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.